Stromal fibroblasts in cancer initiation and progression

NA Bhowmick, EG Neilson, HL Moses - Nature, 2004 - nature.com
It is widely accepted that the development of carcinoma — the most common form of human
cancer — is due to the accumulation of somatic mutations in epithelial cells. The behaviour …

TGFβ: the molecular Jekyll and Hyde of cancer

B Bierie, HL Moses - Nature Reviews Cancer, 2006 - nature.com
Transforming growth factor-β (TGFβ) signalling regulates cancer through mechanisms that
function either within the tumour cell itself or through host–tumour cell interactions. Studies of …

Growth factors and cancer

AS Goustin, EB Leof, GD Shipley, HL Moses - Cancer research, 1986 - AACR
… The D factor induces differentiation of the human promyelocytic leukemia cell line HL-60 (216);
chemical treatment of HL-60 cells leads to an induction of the c-fms proto-oncogene (205…

[PDF][PDF] Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival

…, P Sharma, P Heidari, U Mahmood, L Chin, HL Moses… - Cancer cell, 2014 - cell.com
Pancreatic ductal adenocarcinoma (PDAC) is associated with marked fibrosis and stromal
myofibroblasts, but their functional contribution remains unknown. Transgenic mice with the …

TGF-฿ signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia

…, S Shappell, MK Washington, EG Neilson, HL Moses - Science, 2004 - science.org
Stromal cells can have a significant impact on the carcinogenic process in adjacent epithelia.
The role of transforming growth factor–β (TGF-β) signaling in such epithelial-mesenchymal …

Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta.

AE Postlethwaite, J Keski-Oja, HL Moses… - The Journal of …, 1987 - rupress.org
Transforming growth factor beta (TGF-beta) is a potent chemoattractant in vitro for human
dermal fibroblasts. Intact disulfide and perhaps the dimeric structure of TGF-beta is essential for …

Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium.

RM Lyons, J Keski-Oja, HL Moses - The Journal of cell biology, 1988 - rupress.org
… However, repeated freezing and thawing appeared to result in so'me degree of activation
(Lyons, RM, and HL Moses, unpublished data). Therefore, untreated conditioned medium was …

[HTML][HTML] Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection

…, XI Chen, MV Estrada, KN Johnson, Y Shyr, HL Moses… - PloS one, 2016 - journals.plos.org
Triple-negative breast cancer (TNBC) is a heterogeneous disease that can be classified into
distinct molecular subtypes by gene expression profiling. Considered a difficult-to-treat …

Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism

…, ME Engel, CL Arteaga, HL Moses - Molecular biology of …, 2001 - Am Soc Cell Biol
… Each of the lines selected for further studies were TGF-β sensitive for growth inhibition and
EMT (Bhowmick and Moses, unpublished data). NMuMG cells were infected with virus by …

TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression

L Yang, Y Pang, HL Moses - Trends in immunology, 2010 - cell.com
Transforming growth factor β (TGF-β) plays an important role in tumor initiation and progression,
functioning as both a suppressor and a promoter. The mechanisms underlying this dual …